EMG Biofeedback-Assisted Relaxation Training in the Treatment of Reactive Depression in Chronic Pain Patients

Peniston, Eugene G.; Hughes, Robert B.; Kulkosky, Paul J.

doi:10.1007/bf03394967

Cited by 5 publications

(3 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In general, successful treatment of depression tends to be accompanied by an increase in heart rate variability (Apelbaum, 2001;Balogh et al, 1993;Chambers & Allen, 2002;Khaykin et al, 1998;McGrady, 1994;Peniston, Hughes, & Kulkosky, 1986). We therefore hypothesized that a treatment targeted at increasing HRV and vagal tone might help treat MDD.…”

Section: Depression and Autonomic Dysfunctionmentioning

confidence: 96%

Preliminary Results of an Open Label Study of Heart Rate Variability Biofeedback for the Treatment of Major Depression

Karavidas¹,

Lehrer²,

Vaschillo

et al. 2007

Appl Psychophysiol Biofeedback

387

240

View full text Add to dashboard Cite

show abstract

Section: Depression and Autonomic Dysfunctionmentioning

confidence: 96%

Preliminary Results of an Open Label Study of Heart Rate Variability Biofeedback for the Treatment of Major Depression

Karavidas¹,

Lehrer²,

Vaschillo

et al. 2007

Appl Psychophysiol Biofeedback

387

240

View full text Add to dashboard Cite

show abstract

“…Aside from increase in target biological signal biofeedback, experience may influence some psychological traits such as alexithymia [29,30] and promote improvements through these changes. Peniston et al [31] and Klee and Meyer [32] discussed an impact on a learned helplessness as a possible factor of depression improvement with biofeedback. Biofeedback teaches patients that they can avoid aversive stimuli, which is controversial to a learned helplessness mindset and is in line with a self-efficacy mindset.…”

Section: Neural Plasticitymentioning

confidence: 99%

The Current Evidence Levels for Biofeedback and Neurofeedback Interventions in Treating Depression: A Narrative Review

Мельников

2021

Neural Plasticity

View full text Add to dashboard Cite

This article is aimed at showing the current level of evidence for the usage of biofeedback and neurofeedback to treat depression along with a detailed review of the studies in the field and a discussion of rationale for utilizing each protocol. La Vaque et al. criteria endorsed by the Association for Applied Psychophysiology and Biofeedback and International Society for Neuroregulation & Research were accepted as a means of study evaluation. Heart rate variability (HRV) biofeedback was found to be moderately supportable as a treatment of MDD while outcome measure was a subjective questionnaire like Beck Depression Inventory (level 3/5, “probably efficacious”). Electroencephalographic (EEG) neurofeedback protocols, namely, alpha-theta, alpha, and sensorimotor rhythm upregulation, all qualify for level 2/5, “possibly efficacious.” Frontal alpha asymmetry protocol also received limited evidence of effect in depression (level 2/5, “possibly efficacious”). Finally, the two most influential real-time functional magnetic resonance imaging (rt-fMRI) neurofeedback protocols targeting the amygdala and the frontal cortices both demonstrate some effectiveness, though lack replications (level 2/5, “possibly efficacious”). Thus, neurofeedback specifically targeting depression is moderately supported by existing studies (all fit level 2/5, “possibly efficacious”). The greatest complication preventing certain protocols from reaching higher evidence levels is a relatively high number of uncontrolled studies and an absence of accurate replications arising from the heterogeneity in protocol details, course lengths, measures of improvement, control conditions, and sample characteristics.

show abstract

“…Despite the reported association between HRV and depression, however, there are conflicting observations on HRV in major depression. HRV increased after successful pharmacological and cognitive-behavioral therapy (Apelbaum, 2001; Balogh, Fitzpatrick, Hendricks, & Paige, 1993; Chambers & Allen, 2002; Khaykin et al, 1998; McGrady, 1994; Peniston, Hughes, & Kulkosky, 1986; Ross, Quitkin, & Klein, 2002; Sala et al, 2009), but HRV was found not to differ between healthy controls and physically healthy depressed adults (Sayar, Güleç, Gökçe, & Ak, 2002; Yeragani et al, 1991). A correlation between reduced HRV and severity of disease has been described in major depressive disorder, with the HRV abnormalities not being resolved by pharmacological therapy (Kemp et al, 2010), whereas a study on a large patient population, adjusted for relevant covariates, suggests that antidepressants but not major depression per se reduce HRV, therefore implying a possible side effect of antidepressant medication on HRV (Licht, de Geus, van Dyck, & Penninx, 2010; Licht, Penninx, & de Geus, 2011).…”

Section: Hrv Measures and Measurementmentioning

confidence: 99%

Heart Rate Variability, Homeostasis, and Brain Function

Riganello

Garbarino

Sannita

2012

Journal of Psychophysiology

View full text Add to dashboard Cite

Measures of heart rate variability (HRV) are major indices of the sympathovagal balance in cardiovascular research. These measures are thought to reflect complex patterns of brain activation as well and HRV is now emerging as a descriptor thought to provide information on the nervous system organization of homeostatic responses in accordance with the situational requirements. Current models of integration equate HRV to the affective states as parallel outputs of the central autonomic network, with HRV reflecting its organization of affective, physiological, “cognitive,” and behavioral elements into a homeostatic response. Clinical application is in the study of patients with psychiatric disorders, traumatic brain injury, impaired emotion-specific processing, personality, and communication disorders. HRV responses to highly emotional sensory inputs have been identified in subjects in vegetative state and in healthy or brain injured subjects processing complex sensory stimuli. In this respect, HRV measurements can provide additional information on the brain functional setup in the severely brain damaged and would provide researchers with a suitable approach in the absence of conscious behavior or whenever complex experimental conditions and data collection are impracticable, as it is the case, for example, in intensive care units.

show abstract

EMG Biofeedback-Assisted Relaxation Training in the Treatment of Reactive Depression in Chronic Pain Patients

Cited by 5 publications

References 29 publications

Preliminary Results of an Open Label Study of Heart Rate Variability Biofeedback for the Treatment of Major Depression

Preliminary Results of an Open Label Study of Heart Rate Variability Biofeedback for the Treatment of Major Depression

The Current Evidence Levels for Biofeedback and Neurofeedback Interventions in Treating Depression: A Narrative Review

Heart Rate Variability, Homeostasis, and Brain Function

Contact Info

Product

Resources

About